By Heather Landi – October 3, 2025
GoodRx shares jumped this week after the company announced an expanded partnership with national retail pharmacy Kroger and following news about the launch of TrumpRx, a government-run, direct-to-consumer website.
The company, a prescription drug savings platform, saw its shares gain more than 14% this week. Shares were up nearly 5% Friday morning.
The White House announced Tuesday it was rolling out a direct-to-consumer website, where individuals can buy prescription medications at discounted prices, rather than through insurance. President Donald Trump announced a deal with Pfizer to sell drugs directly to consumers at discounted prices through TrumpRx, offering savings of up to 85%, with most savings averaging at about 50%.
The new website was unveiled as part of the Trump administration’s broader effort to implement a “most favored nation” (MFN) pricing model for prescription drugs.
A senior administration official told NBC News that the Trump administration hopes to launch the TrumpRx website and implement the new pricing for Medicaid patients by “early 2026.”
